Skip to search formSkip to main contentSkip to account menu

Lambda Z

Known as: LAMZ 
The first order rate constant associated with the terminal (log-linear) portion of the curve.
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SDTM Pharmacokinetic Parameter Long Name TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Pharmacokinetics and tolerability of aminosidine after repeated administrations using an optimal dose regimen in healthy dogs and in dogs with leishmaniosis.
2009
2009
Choroba lekkich łańcuchów lambda z wysiękiem plazmocytowym w osierdziu i opłucnej
2008
2008
Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).
OBJECTIVE A study was conducted to assess the bioequivalence of two limaprost alfadex 5 microg tablets, a moisture-resistant… 
2004
2004
Developmental Pharmacokinetics and Pharmacodynamics of Nizatidine
Objectives: To characterize the impact of development on the pharmacokinetics and pharmacodynamics of nizatidine. Methods… 
2003
2003
Effect of Unilateral Nephrectomy on the Pharmacokinetics of Atenolol in Humans
Unilateral nephrectomy is a common surgical procedure and involves functional adaptation of the remaining kidney. There is a… 
2000
2000
Pharmacokinetics, Pharmacodynamics, and Safety of a Platelet GPIIb/IIIa Antagonist, RGD891, following Intravenous Administration in Healthy Male Volunteers
The pharmacokinetics (PK), pharmacodynamics (PD), and safety of a platelet GPIIb/IIIa receptor antagonist, RGD891, and its active… 
1993
1993
Pharmacokinetic study of a tripeptide HIV‐1 protease inhibitor, KNI‐174, in rats after intravenous and intraduodenal administrations
Recently, as a new type of anti‐AIDS drug, an HIV‐1 protease inhibitor, KNI‐174, has been synthesized; it shows a potent and… 
1993
1993
A Phase I Dose‐Ranging Safety and Pharmacokinetics Study of a Novel Oral Thromboxane Synthase Inhibitor, FCE 22, 178
A 100‐ to 3200‐mg dose range of FCE 22,178 was studied in this phase I single‐dose escalation safety/kinetics study. After oral… 
1988
1988
Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria.
1. Chloroquine diphosphate (15 mg base kg-1) was given by constant rate intravenous infusion to two groups of Thai subjects… 
1986
1986
Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers.
1 The pharmacokinetic characteristics and bioavailability of isoxicam were investigated in healthy male volunteers following… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)